{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:16:30Z","timestamp":1794557790737,"version":"4.9.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T00:00:00Z","timestamp":1632441600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>In the UK, annual influenza vaccination is currently recommended for adults aged 16\u201364\u2009years who are in a clinical at-risk group. Despite recommendations, rates of vaccine uptake in the UK have historically been low and below national and international targets. This study aims to analyse vaccine uptake among adults in clinical at-risk groups from the 2015\u20132016 influenza season to the present.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A retrospective analysis of influenza vaccine coverage in the UK was conducted using data extracted from publicly available sources. Clinically at-risk individuals (as defined by Public Health England), including pregnant women, aged 16\u201364\u2009years, were included in this study.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Influenza vaccination coverage rates across the UK in adults aged 16\u201364\u2009years in a clinical at-risk group have been consistently low over the past 5\u2009years, with only 48.0, 42.4, 44.1 and 52.4% of eligible patients in England, Scotland, Wales and Northern Ireland receiving their annual influenza vaccination during the 2018\u20132019 influenza season. Influenza vaccine coverage was lowest in patients with morbid obesity and highest in patients with diabetes in 2018\u20132019. Coverage rates were below current national ambitions of \u226575% in all clinical risk groups. In these clinical at-risk groups, influenza vaccine coverage decreased between 2015 and 2019, and there was considerable regional variation.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Uptake of the influenza vaccine by adults aged 16\u201364\u2009years in a clinical at-risk group was substantially below the national ambitions. As a result, many individuals in the UK remain at high risk of developing severe influenza or complications. Given that people who are vulnerable to COVID-19 are also at increased risk of complications from influenza, during the 2020\u20132021 season, there is a heightened need for healthcare professionals across the UK to address suboptimal vaccine uptake, particularly in at-risk patients. Healthcare professionals and policymakers should consider measures targeted at increasing access to and awareness of the clinical benefits of the influenza vaccine.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12889-021-11736-2","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T05:11:53Z","timestamp":1632460313000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":34,"title":["Influenza vaccine uptake among at-risk adults (aged 16\u201364\u2009years) in the UK: a retrospective database analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Simon","family":"Oakley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julien","family":"Bouchet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,24]]},"reference":[{"issue":"1","key":"11736_CR1","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1186\/s13054-019-2539-x","volume":"23","author":"AC Kalil","year":"2019","unstructured":"Kalil AC, Thomas PG. Influenza virus-related critical illness: pathophysiology and epidemiology. Crit Care. 2019;23(1):258. https:\/\/doi.org\/10.1186\/s13054-019-2539-x.","journal-title":"Crit Care"},{"key":"11736_CR2","unstructured":"Global Burden of Disease. Influenza Collaborators. Mortality, morbidity, and hospitalisations due to influenza lower respiratory tract infections, 2017: an analysis for the Global Burden of Disease Study 2017. Lancet Respir Med. 2019;7(1):69\u201389."},{"key":"11736_CR3","unstructured":"Public Health England. Surveillance of influenza and other respiratory viruses in the UK Winter 2019 to 2020 [cited 2021 September]. Available from: https:\/\/www.gov.uk\/government\/statistics\/annual-flu-reports"},{"issue":"4","key":"11736_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.jinf.2013.11.013","volume":"68","author":"D Cromer","year":"2014","unstructured":"Cromer D, van Hoek AJ, Jit M, Edmunds WJ, Fleming D, Miller E. The burden of influenza in England by age and clinical risk group: a statistical analysis to inform vaccine policy. J Inf Secur. 2014;68(4):363\u201371. https:\/\/doi.org\/10.1016\/j.jinf.2013.11.013.","journal-title":"J Inf Secur"},{"issue":"aug23 1","key":"11736_CR5","doi-asserted-by":"publisher","first-page":"f5061","DOI":"10.1136\/bmj.f5061","volume":"347","author":"D Mertz","year":"2013","unstructured":"Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347(aug23 1):f5061. https:\/\/doi.org\/10.1136\/bmj.f5061.","journal-title":"BMJ."},{"issue":"7","key":"11736_CR6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001053","volume":"8","author":"MD Van Kerkhove","year":"2011","unstructured":"Van Kerkhove MD, Vandemaele KA, Shinde V, Jaramillo-Gutierrez G, Koukounari A, Donnelly CA, et al. Risk factors for severe outcomes following 2009 influenza a (H1N1) infection: a global pooled analysis. PLoS Med. 2011;8(7):e1001053. https:\/\/doi.org\/10.1371\/journal.pmed.1001053.","journal-title":"PLoS Med"},{"key":"11736_CR7","unstructured":"Vaccines against influenza WHO position paper - November 2012. Wkly Epidemiol Rec. 2012;87(47):461\u201376."},{"issue":"1","key":"11736_CR8","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3201\/eid1401.070667","volume":"14","author":"SA Rasmussen","year":"2008","unstructured":"Rasmussen SA, Jamieson DJ, Bresee JS. Pandemic influenza and pregnant women. Emerg Infect Dis. 2008;14(1):95\u2013100. https:\/\/doi.org\/10.3201\/eid1401.070667.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"11736_CR9","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1097\/AOG.0b013e3181d57947","volume":"115","author":"AA Creanga","year":"2010","unstructured":"Creanga AA, Johnson TF, Graitcer SB, Hartman LK, Al-Samarrai T, Schwarz AG, et al. Severity of 2009 pandemic influenza a (H1N1) virus infection in pregnant women. Obstet Gynecol. 2010;115(4):717\u201326. https:\/\/doi.org\/10.1097\/AOG.0b013e3181d57947.","journal-title":"Obstet Gynecol"},{"issue":"1","key":"11736_CR10","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1186\/s12879-019-4318-3","volume":"19","author":"D Mertz","year":"2019","unstructured":"Mertz D, Lo CK, Lytvyn L, Ortiz JR, Loeb M, Flurisk I. Pregnancy as a risk factor for severe influenza infection: an individual participant data meta-analysis. BMC Infect Dis. 2019;19(1):683. https:\/\/doi.org\/10.1186\/s12879-019-4318-3.","journal-title":"BMC Infect Dis"},{"key":"11736_CR11","unstructured":"European Centre for Disease Prevention and Control. Seasonal influenza vaccines. [cited 2021 September]. Available from: https:\/\/www.ecdc.europa.eu\/en\/seasonal-influenza\/prevention-and-control\/seasonal-influenza-vaccines"},{"key":"11736_CR12","unstructured":"Public Health England. The national flu immunisation programme 2020 to 2021- update [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/907149\/Letter_annualflu_2020_to_2021_update.pdf"},{"key":"11736_CR13","unstructured":"WHO SAGE Seasonal Influenza Vaccine Recommendations during the COVID-19 Pandemic. Interim guidance. 21 September 2020 [cited 2021 September]. Available from: https:\/\/www.who.int\/immunization\/policy\/position_papers\/Interim_SAGE_influenza_vaccination_recommendations.pdf?ua=1."},{"issue":"1","key":"11736_CR14","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/s12929-020-0626-6","volume":"27","author":"JR Chen","year":"2020","unstructured":"Chen JR, Liu YM, Tseng YC, Ma C. Better influenza vaccines: an industry perspective. J Biomed Sci. 2020;27(1):33. https:\/\/doi.org\/10.1186\/s12929-020-0626-6.","journal-title":"J Biomed Sci"},{"issue":"3","key":"11736_CR15","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.chom.2015.02.012","volume":"17","author":"K Houser","year":"2015","unstructured":"Houser K, Subbarao K. Influenza vaccines: challenges and solutions. Cell Host Microbe. 2015;17(3):295\u2013300. https:\/\/doi.org\/10.1016\/j.chom.2015.02.012.","journal-title":"Cell Host Microbe"},{"key":"11736_CR16","unstructured":"Public Health England. The national influenza immunisation programme 2020 to 2021. Inactivated influenza vaccine information for healthcare practitioners [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/939960\/Inactivated_influenza_vaccine-information_for_healthcare_practitioners_2020_to_2021_v2.pdf"},{"key":"11736_CR17","unstructured":"Public Health England. The Green Book. Chapter 19: Influenza. Published March 2013. Last updated April 2019 [cited 2021 September]. Available from: https:\/\/www.gov.uk\/government\/collections\/immunisation-against-infectious-disease-the-green-book"},{"issue":"12","key":"11736_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029249","volume":"6","author":"CR Beck","year":"2011","unstructured":"Beck CR, McKenzie BC, Hashim AB, Harris RC, Zanuzdana A, Agboado G, et al. Influenza vaccination for immunocompromised patients: systematic review and meta-analysis from a public health policy perspective. PLoS One. 2011;6(12):e29249. https:\/\/doi.org\/10.1371\/journal.pone.0029249.","journal-title":"PLoS One"},{"issue":"5","key":"11736_CR19","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1159\/000213803","volume":"42","author":"KL Nichol","year":"1996","unstructured":"Nichol KL, Margolis KL, Wouremna J, von Sternberg T. Effectiveness of influenza vaccine in the elderly. Gerontology. 1996;42(5):274\u20139. https:\/\/doi.org\/10.1159\/000213803.","journal-title":"Gerontology."},{"issue":"21","key":"11736_CR20","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1001\/jama.1994.03520210045030","volume":"272","author":"TM Govaert","year":"1994","unstructured":"Govaert TM, Thijs CT, Masurel N, Sprenger MJ, Dinant GJ, Knottnerus JA. The efficacy of influenza vaccination in elderly individuals. A randomized double-blind placebo-controlled trial. JAMA. 1994;272(21):1661\u20135. https:\/\/doi.org\/10.1001\/jama.1994.03520210045030.","journal-title":"JAMA."},{"issue":"17","key":"11736_CR21","doi-asserted-by":"publisher","first-page":"9895","DOI":"10.1128\/JVI.01038-13","volume":"87","author":"CL Loving","year":"2013","unstructured":"Loving CL, Lager KM, Vincent AL, Brockmeier SL, Gauger PC, Anderson TK, et al. Efficacy in pigs of inactivated and live attenuated influenza virus vaccines against infection and transmission of an emerging H3N2 similar to the 2011-2012 H3N2v. J Virol. 2013;87(17):9895\u2013903. https:\/\/doi.org\/10.1128\/JVI.01038-13.","journal-title":"J Virol"},{"issue":"11","key":"11736_CR22","doi-asserted-by":"publisher","first-page":"6019","DOI":"10.1128\/JVI.03101-13","volume":"88","author":"GE Price","year":"2014","unstructured":"Price GE, Lo CY, Misplon JA, Epstein SL. Mucosal immunization with a candidate universal influenza vaccine reduces virus transmission in a mouse model. J Virol. 2014;88(11):6019\u201330. https:\/\/doi.org\/10.1128\/JVI.03101-13.","journal-title":"J Virol"},{"key":"11736_CR23","doi-asserted-by":"crossref","unstructured":"McMahon M, Kirkpatrick E, Stadlbauer D, Strohmeier S, Bouvier NM, Krammer F. Mucosal Immunity against Neuraminidase Prevents Influenza B Virus Transmission in Guinea Pigs. mBio. 2019;10(3).","DOI":"10.1128\/mBio.00560-19"},{"issue":"49","key":"11736_CR24","doi-asserted-by":"publisher","first-page":"7213","DOI":"10.1016\/j.vaccine.2019.09.086","volume":"37","author":"L Friedman","year":"2019","unstructured":"Friedman L, Renaud A, Hines D, Winter A, Bolotin S, Johnstone J, et al. Exploring indirect protection associated with influenza immunization - a systematic review of the literature. Vaccine. 2019;37(49):7213\u201332. https:\/\/doi.org\/10.1016\/j.vaccine.2019.09.086.","journal-title":"Vaccine."},{"issue":"11","key":"11736_CR25","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1086\/657089","volume":"202","author":"WP Glezen","year":"2010","unstructured":"Glezen WP, Gaglani MJ, Kozinetz CA, Piedra PA. Direct and indirect effectiveness of influenza vaccination delivered to children at school preceding an epidemic caused by 3 new influenza virus variants. J Infect Dis. 2010;202(11):1626\u201333. https:\/\/doi.org\/10.1086\/657089.","journal-title":"J Infect Dis"},{"key":"11736_CR26","doi-asserted-by":"crossref","unstructured":"Pebody RG, Green HK, Andrews N, Boddington NL, Zhao H, Yonova I, et al. Uptake and impact of vaccinating school age children against influenza during a season with circulation of drifted influenza A and B strains, England, 2014\/15. Euro Surveill. 2015;20(39).","DOI":"10.2807\/1560-7917.ES.2015.20.39.30029"},{"key":"11736_CR27","doi-asserted-by":"crossref","unstructured":"Pebody RG, Green HK, Andrews N, Zhao H, Boddington N, Bawa Z, et al. Uptake and impact of a new live attenuated influenza vaccine programme in England: early results of a pilot in primary school-age children, 2013\/14 influenza season. Euro Surveill. 2014;19(22).","DOI":"10.2807\/ese.19.22.20823-en"},{"key":"11736_CR28","doi-asserted-by":"crossref","unstructured":"Pebody RG, Sinnathamby MA, Warburton F, Andrews N, Boddington NL, Zhao H, et al. Uptake and impact of vaccinating primary school-age children against influenza: experiences of a live attenuated influenza vaccine programme, England, 2015\/16. Euro Surveill. 2018;23(25).","DOI":"10.2807\/1560-7917.ES.2018.23.25.1700496"},{"issue":"3","key":"11736_CR29","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jhin.2014.01.005","volume":"86","author":"E Amodio","year":"2014","unstructured":"Amodio E, Restivo V, Firenze A, Mammina C, Tramuto F, Vitale F. Can influenza vaccination coverage among healthcare workers influence the risk of nosocomial influenza-like illness in hospitalized patients? J Hosp Infect. 2014;86(3):182\u20137. https:\/\/doi.org\/10.1016\/j.jhin.2014.01.005.","journal-title":"J Hosp Infect"},{"key":"11736_CR30","doi-asserted-by":"publisher","first-page":"178247","DOI":"10.1155\/2015\/178247","volume":"2015","author":"AM Wendelboe","year":"2015","unstructured":"Wendelboe AM, Grafe C, McCumber M, Anderson MP. Inducing herd immunity against seasonal influenza in long-term care facilities through employee vaccination coverage: a transmission dynamics model. Comput Math Methods Med. 2015;2015:178247\u20136. https:\/\/doi.org\/10.1155\/2015\/178247.","journal-title":"Comput Math Methods Med"},{"issue":"1","key":"11736_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169023","volume":"12","author":"AC Hayward","year":"2017","unstructured":"Hayward AC. Influenza vaccination of healthcare workers is an important approach for reducing transmission of influenza from staff to vulnerable patients. PLoS One. 2017;12(1):e0169023. https:\/\/doi.org\/10.1371\/journal.pone.0169023.","journal-title":"PLoS One"},{"issue":"1","key":"11736_CR32","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12879-017-2399-4","volume":"17","author":"M Eichner","year":"2017","unstructured":"Eichner M, Schwehm M, Eichner L, Gerlier L. Direct and indirect effects of influenza vaccination. BMC Infect Dis. 2017;17(1):308. https:\/\/doi.org\/10.1186\/s12879-017-2399-4.","journal-title":"BMC Infect Dis"},{"key":"11736_CR33","unstructured":"Public Health England. Historical vaccine development and introduction of routine vaccine programmes in the UK [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/816174\/Vaccine_Timeline_2019.pdf."},{"key":"11736_CR34","unstructured":"Joint Committee on Vaccination and Immunisation. Minutes of the meeting on 4 June 2014 [cited 2021 September]. Available from: https:\/\/app.box.com\/s\/iddfb4ppwkmtjusir2tc\/file\/229171860655."},{"key":"11736_CR35","unstructured":"Joint Committee on Vaccination and Immunisation. Minutes of the meeting on 6 October 2010 [cited 2021 September]. Available from: https:\/\/webarchive.nationalarchives.gov.uk\/20120907095400\/http:\/\/www.dh.gov.uk\/ab\/JCVI\/DH_107556#_2."},{"issue":"52","key":"11736_CR36","doi-asserted-by":"publisher","first-page":"6691","DOI":"10.1016\/j.vaccine.2016.10.078","volume":"34","author":"K Hardt","year":"2016","unstructured":"Hardt K, Bonanni P, King S, Santos JI, El-Hodhod M, Zimet GD, et al. Vaccine strategies: Optimising outcomes. Vaccine. 2016;34(52):6691\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2016.10.078.","journal-title":"Vaccine."},{"issue":"5","key":"11736_CR37","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/j.vaccine.2011.11.104","volume":"30","author":"CS Ambrose","year":"2012","unstructured":"Ambrose CS, Wu X, Knuf M, Wutzler P. The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: a meta-analysis of 8 randomized controlled studies. Vaccine. 2012;30(5):886\u201392. https:\/\/doi.org\/10.1016\/j.vaccine.2011.11.104.","journal-title":"Vaccine."},{"issue":"10","key":"11736_CR38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001527","volume":"10","author":"M Baguelin","year":"2013","unstructured":"Baguelin M, Flasche S, Camacho A, Demiris N, Miller E, Edmunds WJ. Assessing optimal target populations for influenza vaccination programmes: an evidence synthesis and modelling study. PLoS Med. 2013;10(10):e1001527. https:\/\/doi.org\/10.1371\/journal.pmed.1001527.","journal-title":"PLoS Med"},{"key":"11736_CR39","unstructured":"Joint Committee on Vaccination and Immunisation. JCVI statement on the annual influenza vaccination programme \u2013 extension of the programme to children. 25 July 2012 [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/224775\/JCVI-statement-on-the-annual-influenza-vaccination-programme-25-July-2012.pdf"},{"key":"11736_CR40","unstructured":"World Health Organization. Global influenza strategy 2019\u20132030 [cited 2021 September]. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/311184\/9789241515320-eng.pdf?sequence=18&isAllowed=y"},{"key":"11736_CR41","unstructured":"European Union Council. Council recommendation of 22 December 2009 on seasonal influenza vaccination [cited 2021 September]. Available from: https:\/\/eur-lex.europa.eu\/LexUriServ\/LexUriServ.do?uri=OJ:L:2009:348:0071:0072:EN:PDF"},{"key":"11736_CR42","unstructured":"European Centre for Disease Prevention and Control. Risk groups for severe influenza [cited 2021 September]. Available from: https:\/\/www.ecdc.europa.eu\/en\/seasonal-influenza\/prevention-and-control\/vaccines\/risk-groups"},{"key":"11736_CR43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7573\/dic.2020-9-5","volume":"10","author":"G Kassianos","year":"2021","unstructured":"Kassianos G, Banerjee A, Baron-Papillon F, Hampson AW, McElhaney JE, McGeer A, et al. Key policy and programmatic factors to improve influenza vaccination rates based on the experience from four high-performing countries. Drugs Context. 2021;10:1\u201313. https:\/\/doi.org\/10.7573\/dic.2020-9-5.","journal-title":"Drugs Context"},{"key":"11736_CR44","unstructured":"Public Health England. Influenza immunisation programme for England. GP patient groups. Data collection survey. Season 2018 to 2019 [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/804889\/Seasonal_influenza_vaccine_uptake_in_GP_patients_1819.pdf"},{"key":"11736_CR45","unstructured":"Public Health England. Influenza immunisation programme for England. GP patient groups. Data collection survey. Season 2019 to 2020 [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/912099\/Annual-Report_SeasonalFlu-Vaccine_GPs_2019-20_FINAL_amended.pdf."},{"key":"11736_CR46","unstructured":"Public Health England. Seasonal flu vaccine uptake in children of primary school age: Winter 2018 to 2019 [cited 2020 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/806289\/Childhood_flu_annual_report_2018_19_FINAL_.pdf"},{"key":"11736_CR47","unstructured":"Public Health England. Seasonal flu vaccine uptake in children of primary school age: Winter 2019 to 2020 [cited 2020 September]. Available from: https:\/\/www.gov.uk\/government\/statistics\/seasonal-flu-vaccine-uptake-in-children-of-primary-school-age-winter-2019-to-2020"},{"key":"11736_CR48","unstructured":"Public Health England. Seasonal flu vaccine uptake in healthcare workers (HCWs) in England: Winter season 2018 to 2019 [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/804885\/Seasonal_influenza_vaccine_uptake-HCWs-2018_Final.pdf"},{"key":"11736_CR49","unstructured":"Public Health England. Seasonal flu vaccine uptake in healthcare workers (HCWs) in England: Winter season 2019 to 2020 [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/894751\/Seasonal_influenza_vaccine_uptake_in_healthcare_workers__HCWs__in_Englan....pdf"},{"key":"11736_CR50","unstructured":"Oakley S, Bouchet J, Costello P. Flu vaccination uptake in the UK in at-risk groups: review. Practice Nurse. 2019;September:12\u20136."},{"key":"11736_CR51","doi-asserted-by":"publisher","first-page":"100054","DOI":"10.1016\/j.jvacx.2020.100054","volume":"4","author":"MM Loiacono","year":"2020","unstructured":"Loiacono MM, Mahmud SM, Chit A, van Aalst R, Kwong JC, Mitsakakis N, et al. Patient and practice level factors associated with seasonal influenza vaccine uptake among at-risk adults in England, 2011 to 2016: an age-stratified retrospective cohort study. Vaccine X. 2020;4:100054. https:\/\/doi.org\/10.1016\/j.jvacx.2020.100054.","journal-title":"Vaccine X"},{"key":"11736_CR52","unstructured":"European Centre for Disease Prevention and Control. Seasonal influenza vaccination and antiviral use in EU\/EEA Member States [cited 2021 September]. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/seasonal-influenza-vaccination-antiviral-use-eu-eea-member-states"},{"issue":"1","key":"11736_CR53","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12889-020-8246-3","volume":"20","author":"O Isler","year":"2020","unstructured":"Isler O, Isler B, Kopsacheilis O, Ferguson E. Limits of the social-benefit motive among high-risk patients: a field experiment on influenza vaccination behaviour. BMC Public Health. 2020;20(1):240. https:\/\/doi.org\/10.1186\/s12889-020-8246-3.","journal-title":"BMC Public Health"},{"issue":"1","key":"11736_CR54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s12889-019-6655-y","volume":"19","author":"R Wilson","year":"2019","unstructured":"Wilson R, Paterson P, Larson HJ. Strategies to improve maternal vaccination acceptance. BMC Public Health. 2019;19(1):342. https:\/\/doi.org\/10.1186\/s12889-019-6655-y.","journal-title":"BMC Public Health"},{"issue":"12","key":"11736_CR55","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-023275","volume":"8","author":"D Hungerford","year":"2018","unstructured":"Hungerford D, Ibarz-Pavon A, Cleary P, French N. Influenza-associated hospitalisation, vaccine uptake and socioeconomic deprivation in an English city region: an ecological study. BMJ Open. 2018;8(12):e023275. https:\/\/doi.org\/10.1136\/bmjopen-2018-023275.","journal-title":"BMJ Open"},{"key":"11736_CR56","doi-asserted-by":"crossref","unstructured":"Dexter LJ, Teare MD, Dexter M, Siriwardena AN, Read RC. Strategies to increase influenza vaccination rates: outcomes of a nationwide cross-sectional survey of UK general practice. BMJ Open. 2012;2(3).","DOI":"10.1136\/bmjopen-2011-000851"},{"key":"11736_CR57","unstructured":"National Centre for Health and Care Excellence (NICE). Flu vaccination: increasing uptake. NG103 [cited 2021 September]. Available from: https:\/\/www.nice.org.uk\/guidance\/ng103\/resources\/flu-vaccination-increasing-uptake-pdf-66141536272837"},{"key":"11736_CR58","unstructured":"National Centre for Health and Care Excellence (NICE). Quality standards and indicators briefing paper. Flu vaccination: increasing uptake. [cited 2021 September]. Available from: https:\/\/www.google.co.uk\/url?sa=t&rct=j&q=&esrc=s&source=web&cd=&ved=2ahUKEwiNwvaDw5XrAhUDy6QKHZqyADQQFjAQegQICRAB&url=https%3A%2F%2Fwww.nice.org.uk%2Fguidance%2FGID-QS10071%2Fdocuments%2Fbriefing-paper&usg=AOvVaw3VspD0BQ88VIp_LQi1UeVE"},{"key":"11736_CR59","doi-asserted-by":"crossref","unstructured":"Bachtiger P, Adamson A, Chow J-J, Sisodia R, Quint JK, Peters NS. The Impact of the Covid-19 Pandemic on Uptake of Influenza Vaccine: A UK-Wide Observational Study. medRxiv. 2020:2020.10.01.20205385.","DOI":"10.2196\/preprints.26734"},{"key":"11736_CR60","unstructured":"Public Health England. Weekly national influenza and COVID-19 surveillance report. Week 1 report (up to week 53 data). 7 January 2021 [cited 2021 September]. Available from: https:\/\/assets.publishing.service.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/950424\/Weekly_Flu_and_COVID-19_report_w1_FINAL.PDF"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11736-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-021-11736-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-021-11736-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T05:13:01Z","timestamp":1632460381000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-021-11736-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,24]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["11736"],"URL":"https:\/\/doi.org\/10.1186\/s12889-021-11736-2","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,24]]},"assertion":[{"value":"18 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"SO, JB, PC and JP are employees of Sanofi Pasteur.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1734"}}